Enterococcus faecalis and Enterococcus faecium

The data refers to isolates non-susceptible to the designated antimicrobials.

Pig

Year (September to August)	Total	Ampicillin				Tigecycline				Levofloxacin				Gentamicin				Streptomycin
		Intermediate + Resistant (I+R)		Resistant Only (R)*		Intermediate + Resistant (I+R)		Resistant Only (R)*		Intermediate + Resistant (I+R)		Resistant Only (R)*		Intermediate + Resistant (I+R)		Resistant Only (R)*		Intermediate + Resistant (I+R)		Resistant Only (R)*
		No.	%	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%
2009 / 2010	55	0	0.0	-	-	0	0.0	-	-	13	23.6	-	-	22	40.0	-	-	25	45.5	-	-
2010 / 2011	39	0	0.0	-	-	0	0.0	-	-	7	17.9	-	-	16	41.0	-	-	15	38.5	-	-
2011 / 2012	47	0	0.0	-	-	0	0.0	-	-	14	29.8	-	-	20	42.6	-	-	20	42.6	-	-
2012 / 2013^{^}	67	1	1.5	-	-	0	0.0	-	-	19	28.4	-	-	24	35.8	-	-	25	37.3	-	-
2013 / 2014^{^}	64	1	1.6	-	-	0	0.0	-	-	22	34.4	-	-	30	46.9	-	-	32	50.0	-	-
2014 / 2015	46	0	0.0	-	-	0	0.0	-	-	12	26.1	-	-	21	45.7	-	-	24	52.2	-	-
2015 / 2016	31	0	0.0	-	-	0	0.0	-	-	7	22.6	-	-	14	45.2	-	-	15	48.4	-	-
2016 / 2017	22	0	0.0	-	-	0	0.0	-	-	8	36.4	-	-	11	50.0	-	-	9	40.9	-	-
2017 / 2018	9	0	0.0	-	-	0	0.0	-	-	1	11.1	-	-	1	11.1	-	-	2	22.2	-	-
2018 / 2019	5	0	0.0	-	-	0	0.0	-	-	1	20.0	-	-	3	60.0	-	-	4	80.0	-	-
2019 / 2020	25	3	12.0	-	-	0	0.0	-	-	8	32.0	-	-	3	12.0	-	-	5	20.0	-	-
2020 / 2021	32	0	0.0	-	-	0	0.0	-	-	7	21.9	-	-	3	9.4	-	-	3	9.4	-	-
2021 / 2022	43	0	0.0	-	-	0	0.0	-	-	9	20.9	-	-	8	18.6	-	-	7	16.3	-	-
2022 / 2023	33	0	0.0	-	-	1	3.0	-	-	13	39.4	-	-	7	21.2	-	-	7	21.2	-	-
2023 / 2024	33	1	3.0	-	-	0	0.0	-	-	7	21.2	-	-	13	39.4	-	-	12	36.4	-	-
2024 / 2025	41	0	0.0	0	0.0	0	0.0	0	0.0	10	24.4	10	24.4	8	19.5	8	19.5	10	24.4	10	24.4

Footnotes:
* Resistant only (R) count and percentage available from 2025 onwards.
^ One isolate was resistant to vancomycin and positive for vanA gene (lineage ST6).
Data refers to Enterococcus isolates from animals in slaughterhouse in Hong Kong.
Specimens were obtained from animals in slaughterhouse in Hong Kong.

Chicken

Year (September to August)	Total	Ampicillin				Tigecycline				Levofloxacin				Gentamicin				Streptomycin
		Intermediate + Resistant (I+R)		Resistant Only (R)*		Intermediate + Resistant (I+R)		Resistant Only (R)*		Intermediate + Resistant (I+R)		Resistant Only (R)*		Intermediate + Resistant (I+R)		Resistant Only (R)*		Intermediate + Resistant (I+R)		Resistant Only (R)*
		No.	%	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%
2009 / 2010	99	0	0.0	-	-	0	0.0	-	-	50	50.5	-	-	24	24.2	-	-	40	40.4	-	-
2010 / 2011	36	0	0.0	-	-	0	0.0	-	-	19	52.8	-	-	10	27.8	-	-	17	47.2	-	-
2011 / 2012	69	0	0.0	-	-	0	0.0	-	-	39	56.5	-	-	21	30.4	-	-	41	59.4	-	-
2012 / 2013	32	0	0.0	-	-	0	0.0	-	-	24	75.0	-	-	16	50.0	-	-	17	53.1	-	-
2013 / 2014	30	1	3.3	-	-	0	0.0	-	-	11	36.7	-	-	14	46.7	-	-	17	56.7	-	-
2014 / 2015	26	0	0.0	-	-	0	0.0	-	-	7	26.9	-	-	16	61.5	-	-	12	46.2	-	-
2015 / 2016	22	0	0.0	-	-	0	0.0	-	-	11	50.0	-	-	15	68.2	-	-	16	72.7	-	-
2016 / 2017	21	0	0.0	-	-	0	0.0	-	-	7	33.3	-	-	10	47.6	-	-	5	23.8	-	-
2017 / 2018	31	0	0.0	-	-	1	3.2	-	-	9	29.0	-	-	10	32.3	-	-	11	35.5	-	-
2018 / 2019	19	2	10.5	-	-	0	0.0	-	-	11	57.9	-	-	6	31.6	-	-	11	57.9	-	-
2019 / 2020	18	0	0.0	-	-	0	0.0	-	-	6	33.3	-	-	9	50.0	-	-	2	11.1	-	-
2020 / 2021	31	0	0.0	-	-	0	0.0	-	-	7	22.6	-	-	14	45.2	-	-	14	45.2	-	-
2021 / 2022	25	0	0.0	-	-	0	0.0	-	-	9	36.0	-	-	10	40.0	-	-	12	48.0	-	-
2022 / 2023	22	1	4.5	-	-	0	0.0	-	-	11	50.0	-	-	7	31.8	-	-	14	63.6	-	-
2023 / 2024	3	0	0.0	-	-	0	0.0	-	-	2	66.7	-	-	2	66.7	-	-	2	66.7	-	-
2024 / 2025	20	0	0.0	0	0.0	0	0.0	0	0.0	5	25.0	4	20.0	10	50.0	10	50.0	12	60.0	12	60.0

Footnotes:
* Resistant only (R) count and percentage available from 2025 onwards.
All isolates were susceptible to vancomycin.
Data refers to Enterococcus isolates from animals in wet markets in Hong Kong.
Specimens were obtained from animals in wet markets in Hong Kong.

Rodent

Year (September to August)	Total	Ampicillin				Tigecycline				Levofloxacin				Gentamicin				Streptomycin
		Intermediate + Resistant (I+R)		Resistant Only (R)*		Intermediate + Resistant (I+R)		Resistant Only (R)*		Intermediate + Resistant (I+R)		Resistant Only (R)*		Intermediate + Resistant (I+R)		Resistant Only (R)*		Intermediate + Resistant (I+R)		Resistant Only (R)*
		No.	%	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%
2009 / 2010	105	0	0.0	-	-	0	0.0	-	-	3	2.9	-	-	8	7.6	-	-	12	11.4	-	-
2010 / 2011	101	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-	1	1.0	-	-
2011 / 2012	62	0	0.0	-	-	0	0.0	-	-	1	1.6	-	-	0	0.0	-	-	0	0.0	-	-
2012 / 2013	39	0	0.0	-	-	0	0.0	-	-	2	5.1	-	-	1	2.6	-	-	3	7.7	-	-
2013 / 2014	35	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-	3	8.6	-	-	3	8.6	-	-
2014 / 2015	47	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-
2015 / 2016	29	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-	1	3.4	-	-	0	0.0	-	-
2016 / 2017	10	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-	1	10.0	-	-
2017 / 2018	15	0	0.0	-	-	0	0.0	-	-	1	6.7	-	-	1	6.7	-	-	1	6.7	-	-
2018 / 2019	10	0	0.0	-	-	0	0.0	-	-	3	30.0	-	-	0	0.0	-	-	0	0.0	-	-
2019 / 2020	18	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-
2020 / 2021	13	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-
2021 / 2022	11	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-
2022 / 2023	13	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-
2023 / 2024	3	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-
2024 / 2025	19	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0

Footnotes:
* Resistant only (R) count and percentage available from 2025 onwards.
All isolates were susceptible to vancomycin.
Data refers to Enterococcus isolates from urban animals in Hong Kong.
Specimens were obtained from urban animals in Hong Kong.

Cat

Year (September to August)	Total	Ampicillin				Tigecycline				Levofloxacin				Gentamicin				Streptomycin
		Intermediate + Resistant (I+R)		Resistant Only (R)*		Intermediate + Resistant (I+R)		Resistant Only (R)*		Intermediate + Resistant (I+R)		Resistant Only (R)*		Intermediate + Resistant (I+R)		Resistant Only (R)*		Intermediate + Resistant (I+R)		Resistant Only (R)*
		No.	%	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%
2009 / 2010	90	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-	4	4.4	-	-	6	6.7	-	-
2010 / 2011	61	0	0.0	-	-	0	0.0	-	-	1	1.6	-	-	4	6.6	-	-	9	14.8	-	-
2011 / 2012	46	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-	5	10.9	-	-	4	8.7	-	-
2012 / 2013	56	0	0.0	-	-	0	0.0	-	-	2	3.6	-	-	2	3.6	-	-	7	12.5	-	-
2013 / 2014	97	0	0.0	-	-	0	0.0	-	-	10	10.3	-	-	6	6.2	-	-	8	8.2	-	-
2014 / 2015	54	0	0.0	-	-	0	0.0	-	-	4	7.4	-	-	3	5.6	-	-	7	13.0	-	-
2015 / 2016	54	0	0.0	-	-	0	0.0	-	-	2	3.7	-	-	3	5.6	-	-	7	13.0	-	-
2016 / 2017	40	0	0.0	-	-	0	0.0	-	-	5	12.5	-	-	3	7.5	-	-	6	15.0	-	-
2017 / 2018	38	0	0.0	-	-	1	2.6	-	-	2	5.3	-	-	0	0.0	-	-	5	13.2	-	-
2018 / 2019	21	0	0.0	-	-	0	0.0	-	-	2	9.5	-	-	1	4.8	-	-	0	0.0	-	-
2019 / 2020	8	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-
2020 / 2021	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
2021 / 2022	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
2022 / 2023	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
2023 / 2024	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
2024 / 2025	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Footnotes:
* Resistant only (R) count and percentage available from 2025 onwards.
All isolates were susceptible to vancomycin.
Data refers to Enterococcus isolates from stray animals in Hong Kong.
Specimens were obtained from stray animals in Hong Kong.

Dog

Year (September to August)	Total	Ampicillin				Tigecycline				Levofloxacin				Gentamicin				Streptomycin
		Intermediate + Resistant (I+R)		Resistant Only (R)*		Intermediate + Resistant (I+R)		Resistant Only (R)*		Intermediate + Resistant (I+R)		Resistant Only (R)*		Intermediate + Resistant (I+R)		Resistant Only (R)*		Intermediate + Resistant (I+R)		Resistant Only (R)*
		No.	%	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%
2009 / 2010	136	2	1.5	-	-	0	0.0	-	-	4	2.9	-	-	7	5.1	-	-	7	5.1	-	-
2010 / 2011	90	0	0.0	-	-	0	0.0	-	-	3	3.3	-	-	4	4.4	-	-	4	4.4	-	-
2011 / 2012	74	0	0.0	-	-	0	0.0	-	-	2	2.7	-	-	9	12.2	-	-	11	14.9	-	-
2012 / 2013	126	0	0.0	-	-	0	0.0	-	-	3	2.4	-	-	1	0.8	-	-	6	4.8	-	-
2013 / 2014	79	0	0.0	-	-	0	0.0	-	-	6	7.6	-	-	6	7.6	-	-	6	7.6	-	-
2014 / 2015	86	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-	3	3.5	-	-	9	10.5	-	-
2015 / 2016	89	0	0.0	-	-	0	0.0	-	-	9	10.1	-	-	7	7.9	-	-	4	4.5	-	-
2016 / 2017	74	3	4.1	-	-	0	0.0	-	-	19	25.7	-	-	4	5.4	-	-	7	9.5	-	-
2017 / 2018	80	1	1.3	-	-	0	0.0	-	-	5	6.3	-	-	0	0.0	-	-	3	3.8	-	-
2018 / 2019	35	0	0.0	-	-	0	0.0	-	-	6	17.1	-	-	3	8.6	-	-	1	2.9	-	-
2019 / 2020	20	0	0.0	-	-	0	0.0	-	-	2	10.0	-	-	0	0.0	-	-	1	5.0	-	-
2020 / 2021	5	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-	0	0.0	-	-
2021 / 2022	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
2022 / 2023	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
2023 / 2024	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
2024 / 2025	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-